Three Motley Fool contributors think they've found relatively safe stocks to buy right now with major market indexes remaining near correction territory. Here's why they like Abbott Laboratories (NYSE ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

The establishment of Hua Medicine’s pharmaceutical sales and marketing team resulted in significant sales growth in the first ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

A comprehensive assessment reveals that Sri Lanka’s pharmaceutical supply chain, though grounded in strong public access, ...

The PBS works by ensuring that medicines listed on its schedule are subsidized by the government. For example, in the last financial year, the PBS handled about 227 million preions. Cost Structure: ...

The Nigeria Customs Service (NCS) has finally begun the implementation of the President's Executive Order on the importation ...

Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine targeting a chronic blood disorder.

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...

The Weill Cancer Hub East has been established to explore the “interplay” between nutrition and immunotherapy in cancer ...

A Nigerian pharmaceutical company, ST. RACHEAL’S Pharma, has urged President Bola Tinubu to ensure the return of all ...

Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...